![logo2](/ServeContent?url=http%3A%2F%2Fwww.heterocycles.jp%2Fclockss%2Fimg%2Fcycle.gif)
![logo2](/ServeContent?url=http%3A%2F%2Fwww.heterocycles.jp%2Fclockss%2Fimg%2Flogo_box.gif)
HETEROCYCLES
An International Journal for Reviews and Communications in Heterocyclic ChemistryWeb Edition ISSN: 1881-0942
Published online by The Japan Institute of Heterocyclic Chemistry
e-Journal
Full Text HTML
Received, 28th July, 2009, Accepted, 18th August, 2009, Published online, 20th August, 2009.
DOI: 10.3987/COM-09-11803
■ Regioselective Nitroalkylation of the 1-Methyl-2-quinolone Framework
Motoki Asahara, Masaki Ohtsutsumi, Masahiro Ariga, and Nagatoshi Nishiwaki*
School of Science and Technology, Kochi University of Technology, Tosayamada-cho, Kochi, 782-8502, Japan
Abstract
Regioselective introduction of an (α-nitro)alkyl group to the 1-methyl-2-quinolone framework was performed upon treatment of 1-methyl-3,6,8-trinitro-2-quinolone with nitroalkanes in the presence of triethylamine, in which a nitronate anion attacks at the 4-position and the subsequent aromatization by elimination of nitrous acid lead to 4-(α-nitro)alkylated 6,8-dinitro-1-methyl-2-quinolones.The 1-methyl-2-quinolone (MeQone) framework is seen in more than 300 quinoline alkaloids isolated from the Rutaceae family, and the isolation, the structural determination and total syntheses of new quinoline alkaloids concerning MeQone are still active area.1 From the viewpoint of biochemical and pharmacological interests, resercher’s attention is recently turned to not only study on natural products but also preparation of unnatural compounds having the MeQone framework as the partial structure.2 However, the pyridone moiety is not so reactive because of somewhat aromatic property, which prevents functionalization of the MeQone.2 Thus, development of a facile method for modifying the MeQone framework is one of the highly demanded projects.
Among less reactive MeQones, 1-methyl-3,6,8-trinitro-2-quinolone (1)3a has peculiar reactivity caused by steric repulsion between the 1-methyl and the 8-nitro groups,3e which enables functionalization of the MeQone framework. Indeed, a new ring is easily constructed on the [c]-face by cycloaddition with electron-rich diene or electron-rich alkenes,4 and functionalization at the 4-position is also performed by reaction with nucleophiles.3 In this paper, we demonstrate a new method for regioselective C-C bond formation on the MeQone framework by cine-substitution using nitroalkanes (2a-c) as nucleophiles.
When trinitroquinolone (1) was allowed to react with nitroethane (2a) in the presence of triethylamine at room temperature, cine-substituted product (4a) was isolated in 41% yield as a mixture with its tautomer (5a) (Table, run 1). Higher temperature was effective for the present reaction increasing the yield of 4a up to 80% (run 2). 1-Nitropropane (2b) also reacted with 1 to give 4b effectively (runs 3 and 4). On the other hand, a mixture of adduct (3c) and its tautomer (6c) was formed in the reaction of 1 with 2-nitropropane (2c) at room temperature (run 5). At high temperature, further aromatization accompanying elimination of nitrous acid proceeded to afford cine-substituted product (4c) in 77% yield (run 6). Consequently, an (α-nitro)alkyl group was introduced to the MeQone framework regioselectively upon treatment of trinitroquinolone (1) with nitroalkanes (2). Constructing a new family of unnatural MeQones will contribute to the research of biologically active compounds.
EXPERIMENTAL
Melting points were measured on a Yanaco micro melting point apparatus and are uncorrected. The IR spectra were recorded on a JASCO FT/IR-4200 infrared spectrophotometer. The 1H and 13C NMR spectra were measured using a dimethyl sulfoxide-d6 (DMSO-d6) solution on a Brucker DPX-400 at 400 MHz and at 100 MHz respectively with tetramethylsilane (TMS) as an internal standard. 13C NMR assignments were made from DEPT experiments. MS spectra were recorded on a JEOL JMS-AX505HA, and elemental microanalyses were performed using a Yanaco MT-3 CHN corder. All reagents and solvents were commercially available and used as received.
6,8-Dinitro-1-methyl-4-(1-nitroethyl)-2-quinolone (4a) and 1-(1,2-Dihydro-6,8-dinitro-1-methyl-2-oxoquinoline-4-yl)ethanenitronic acid (5a)
To a solution of quinolone 1 (294 mg, 1.0 mmol) in acetonitrile (10 mL), nitroethane (216 µL, 3.0 mmol) and triethylamine (167 µL, 1.2 mmol) were added. After heating under reflux, solvent was removed under reduced pressure. The residue was treated with column chromatography on silica gel to afford cine-substituted quinolone 4a (258 mg, 0.8 mmol, 80% yield, eluted with hexane-EtOAc = 1/1) that contains a small amount of tautomer 5a. After recrystallization from EtOH, all products were converted to nitronic acid 5a. In cases of other nitroalkanes 2b and 2c, reactions were conducted in the same way.
4a including a trace amount of 5a: Yellow powder; mp 165-167 ˚C (decomp). IR (KBr) 1290, 1350, 1469, 1535, 1607, 1679 cm-1; 1H NMR δ 1.96 (d, J = 6.7 Hz, 3H), 3.35 (s, 3H), 6.86 (q, J = 6.7 Hz, 1H), 7.20 (s, 1H), 9.00 (d, J = 2.4 Hz, 1H), 9.02 (d, J = 2.4 Hz, 1H); 13C NMR δ 17.4 (CH3), 34.9 (CH3), 79.7 (CH), 121.4 (C), 122.7 (CH), 123.4 (CH), 123.8 (CH), 137.8 (C), 138.9 (C), 140.2 (C), 143.3 (C), 161.1 (C). 5a: Pale yellow needles; mp 256-258 (decomp). 1H NMR δ 2.67 (s, 3H), 3.35 (s, 3H), 7.08 (s, 1H), 8.93 (d, J = 2.5 Hz, 1H), 9.17 (d, J = 2.5 Hz, 1H), 12.18 (s, 1H); 13C NMR δ 13.3 (CH3), 33.6 (CH3), 119.9 (C), 121.2 (CH), 121.6 (CH), 125.5 (CH), 137.1 (C), 137.7 (C), 139.7 (C), 144.0 (C), 150.3 (s), 160.3 (C). Anal. Calcd for C12H10N4O7: C 44.73, H 3.13, N 17.39. Found: C 45.11, H 2.81, N 17.51.
6,8-Dinitro-1-methyl-4-(1-nitropropyl)-2-quinolone (4b)
Pale yellow powder; mp 132-133 ˚C (decomp). IR (KBr) 1341, 1531, 1559, 1606, 1682 cm-1; 1H NMR δ 1.20 (dd, J = 7.3, 7.3 Hz, 3H), 2.24 (ddq, J = 16.2, 7.3, 5.5 Hz, 1H), 2.67 (ddq, J = 16.2, 9.2, 7.3 Hz, 1H), 3.50 (s, 3H), 5.95 (dd, J = 9.2, 5.5 Hz, 1H), 7.16 (s, 1H), 8.78 (d, J = 2.3 Hz, 1H), 8.93 (d, J = 2.3 Hz, 1H); 13C NMR δ 10.7 (CH3), 26.0 (CH2), 35.3 (CH3), 86.5 (CH), 121.8 (C), 122.6 (CH), 122.7 (CH), 124.7 (CH), 138.2 (C), 139.6 (C), 140.7 (C), 141.0 (C), 161.0 (C). Anal. Calcd for C13H12N4O7: C 46.44, H 3.60, N 16.66. Found: C 46.73, H 3.32, N 16.65.
3,4-Dihydro-1-methyl-4-(2-nitro-2-propyl)-3,6,8-trinitro-2-quinolone (3c) and 6,8-Dinitro-1-methyl-4-(2-nitro-2-propyl)-2-oxo-1,2,3,4-tetrahydroquinoline-3-nitronic acid (6c)
3c: Yellow plates; mp 220-225 °C (decomp). 1H NMR δ 1.62 (s, 3H), 1.75 (s, 3H), 3.04 (s, 3H), 4.96 (d, J = 1.2 Hz, 1H), 6.37 (d, J = 1.2 Hz, 1H), 8.75 (d, J = 2.6 Hz, 1H), 8.78 (d, J = 2.6 Hz, 1H); 13C NMR δ 21.8 (CH3), 23.0 (CH2), 33.3 (CH3), 45.7 (CH), 81.8 (CH), 87.4 (C), 121.5 (CH), 124.2 (C), 128.6 (CH), 137.3 (C), 138.9 (C), 141.6 (C), 158.3 (C); MS (FAB) m/z = 384 (M++1, 42), 368 (100), 350 (73). Anal. Calcd for C13H13N5O9: C 40.74, H 3.42, N 18.27. Found: C 40.62, H 3.57, N 18.65. 6c including a trace amount of 3c: Yellow powder; mp 190-195 °C (decomp). IR (KBr) 1342, 1412, 1528, 1605, 1682, 3569 cm-1; 1H NMR δ 1.36 (s, 3H), 1.59 (s, 3H), 2.77 (s, 3H), 8.22 (d, J = 2.4 Hz, 1H), 8.59 (d, J = 2.4 Hz, 1H), A hydroxy proton was not observed presumably due to overlapping with a signal of water; 13C NMR δ 21.5 (CH3), 24.0 (CH2), 33.6 (CH3), 47.7 (CH), 92.7 (C), 101.5 (C), 120.9 (CH), 126.3 (CH), 130.0 (C), 137.6 (C), 139.8 (C), 139.9 (C), 160.8 (C). It was found that conversion from 3c to 6c predominantly occurred upon treatment with triethylamine, and reverse conversion from 6c to 3c occurred with hydrochloric acid.
6,8-Dinitro-1-methyl-4-(2-nitro-2-propyl)-2-quinolone (4c)
Yellow plates; mp 230-232 °C (decomp). IR (KBr) 1299, 1332, 1348, 1541, 1603, 1683 cm-1; 1H NMR δ 2.16 (s, 6H), 3.36 (s, 3H), 7.24 (s, 1H), 8.22 (d, J = 2.4 Hz, 1H), 8.94 (d, J = 2.4 Hz, 1H); 13C NMR δ 27.0 (CH3), 35.0 (CH2), 89.4 (C), 119.8 (C), 122.2 (CH), 122.4 (CH), 123.6 (CH), 138.2 (C), 139.4 (C), 139.9 (C), 145.4 (C), 161.0 (C); MS (FAB) m/z = 337 (M++1, 82), 291 (100). Anal. Calcd for C13H12N4O7: C 46.44, H 3.60, N 16.66. Found: C 46.66, H 3.42, N 16.68.
References
1. Reviews: a) R. D. Larsen, “Science of Synthesis: Quinolinone,” Vol. 15, ed. by D. Black, Thieme Publishing, New York, 2005, pp. 551-660; b) C. Ito, Nat. Med., 2000, 54, 117; c) M. F. Grundon, “The Alkaloids: Quinoline Alkaloids Realated to Anthranic Acid,” Vol. 32, ed. by A. Brossi, Academic Press, London, 1968, pp. 341-439.
2. For example: a) H. Goemer and T. Wolff, Photochem. Photobiol., 2008, 84, 1224; CrossRef b) R. Fujita, T. Yoshisuji, S. Wakayanagi, H. Wakamatsu, and H. Matsuzaki, Chem. Pharm. Bull., 2006, 54, 204; CrossRef c) J. Hashim, T. N. Glasnov, J. M. Kremsner, and C. O. Kappe, J. Org. Chem., 2006, 71, 1707; CrossRef d) J. Wu, X. Sun, and L. Zhang, Chem. Lett., 2005, 34, 796. CrossRef
3. a) M. Asahara, M. Ohtsutsumi, M. Tamura, N. Nishiwaki, and M. Ariga, Bull. Chem. Soc. Jpn., 2005, 78, 2235; CrossRef b) M. Asahara, M. Nagamatsu, Y. Tohda, N. Nishiwaki, and M. Ariga, Arkivoc, 2005, i, 1; c) M. Asahara, T. Katayama, Y. Tohda, N. Nishiwaki, and M. Ariga, Chem. Pharm. Bull., 2004, 52, 1334; CrossRef d) N. Nishiwaki, M. Sakashita, M. Azuma, C. Tanaka, M. Tamura, N. Asaka, K. Hori, Y. Tohda, and M. Ariga, Tetrahedron, 2002, 58, 473; CrossRef e) N. Nishiwaki, C. Tanaka, M. Asahara, N. Asaka, Y. Tohda, and M. Ariga, Heterocycles, 1999, 51, 567; CrossRef f) N. Nishiwaki, A. Tanaka, M. Uchida, Y. Tohda, and M. Ariga, Bull. Chem. Soc. Jpn., 1996, 69, 1377. CrossRef
4. a) M. Asahara, C. Shibano, K. Koyama, M. Tamura, Y. Tohda, N. Nishiwaki, and M. Ariga, Tetrahedron Lett. 2005, 46, 7519; CrossRef b) M. Asahara, M. Nagamatsu, Y. Tohda, N. Nishiwaki, and M. Ariga, J. Heterocycl. Chem., 2004, 41, 803 CrossRef